A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer
Imugene Limited
Imugene Limited
Numab Therapeutics AG
Novartis
Ikena Oncology
Ikena Oncology
Innovent Biologics (Suzhou) Co. Ltd.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network